Dysautonomia in COVID-19 patients: a narrative review on clinical course, diagnostic and therapeutic strategies
F Carmona-Torre, A Mínguez-Olaondo… - Frontiers in …, 2022 - frontiersin.org
Introduction On March 11, 2020, the World Health Organization sounded the COVID-19
pandemic alarm. While efforts in the first few months focused on reducing the mortality of …
pandemic alarm. While efforts in the first few months focused on reducing the mortality of …
Management of orthostatic hypotension in Parkinson's disease
Orthostatic hypotension (OH) is a common non-motor feature of Parkinson's disease that
may cause unexplained falls, syncope, lightheadedness, cognitive impairment, dyspnea …
may cause unexplained falls, syncope, lightheadedness, cognitive impairment, dyspnea …
Parkinson disease and orthostatic hypotension in the elderly: recognition and management of risk factors for falls
PA LeWitt, S Kymes, RA Hauser - Aging and disease, 2019 - pmc.ncbi.nlm.nih.gov
Parkinson disease (PD) is often associated with postural instability and gait dysfunction that
can increase the risk for falls and associated consequences, including injuries, increased …
can increase the risk for falls and associated consequences, including injuries, increased …
Neurogenic orthostatic hypotension in Parkinson disease: a primer
JK Cutsforth-Gregory, PA Low - Neurology and therapy, 2019 - Springer
Abstract Parkinson disease (PD) is associated with a variety of motor and non-motor clinical
manifestations, including cardiovascular autonomic dysfunction. Neurogenic orthostatic …
manifestations, including cardiovascular autonomic dysfunction. Neurogenic orthostatic …
[HTML][HTML] Cardiovascular safety considerations in the treatment of neurogenic orthostatic hypotension
Neurogenic orthostatic hypotension (nOH), a drop in blood pressure upon standing resulting
from autonomic malfunction, may cause debilitating symptoms that can affect independence …
from autonomic malfunction, may cause debilitating symptoms that can affect independence …
Management strategies for comorbid supine hypertension in patients with neurogenic orthostatic hypotension
Abstract Purpose of Review In autonomic failure, neurogenic orthostatic hypotension (nOH)
and neurogenic supine hypertension (nSH) are interrelated conditions characterized by …
and neurogenic supine hypertension (nSH) are interrelated conditions characterized by …
Evaluating the impact of orthostatic syncope and presyncope on quality of life: a systematic review and meta-analysis
Purpose Syncope (transient loss of consciousness and postural tone) and presyncope are
common manifestations of autonomic dysfunction that are usually triggered by orthostasis …
common manifestations of autonomic dysfunction that are usually triggered by orthostasis …
Pharmacologic treatment of orthostatic hypotension
Neurogenic orthostatic hypotension (OH) is a disabling disorder caused by impairment of
the normal autonomic compensatory mechanisms that maintain upright blood pressure …
the normal autonomic compensatory mechanisms that maintain upright blood pressure …
Durability of the clinical benefit of Droxidopa for neurogenic orthostatic hypotension during 12 weeks of open-label treatment
RA Hauser, A Favit, LA Hewitt, A Lindsten… - Neurology and …, 2022 - Springer
Introduction Droxidopa is approved to treat neurogenic orthostatic hypotension (nOH)
symptoms in patients with autonomic failure based on short-term clinical trial data. Additional …
symptoms in patients with autonomic failure based on short-term clinical trial data. Additional …
Droxidopa management by an integrated health-system specialty pharmacy team
SN Livezey, NB Shah, J DeClercq, J Keefe… - Journal of the American …, 2022 - Elsevier
Background Droxidopa, indicated for the treatment of symptomatic neurogenic orthostatic
hypotension, can be challenging for patients to access owing to manufacturer and payer …
hypotension, can be challenging for patients to access owing to manufacturer and payer …